Indeed, resveratrol treatment of hypertensive rodents reduced systemic levels of HNE, rescued arterial LKB1-AMPK-eNOS activity and attenuated high blood pressure [95], suggesting that resveratrol can improve reactive oxygen species-mediated impaired AMPK-eNOS signaling. The gene discussed is PRKAB1; the disease is hypertensive disorder.